Company intelligence / Profile preview
Nano Intelligent Biomedical Engineering
Seoul, Seoul, South Koreanibe.co.kr ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Nano Intelligent Biomedical Engineering (NIBE) is focused on developing next-generation mRNA delivery systems using proprietary lipid nanoparticle (LNP) technology. The company is currently in the pre-clinical and early development stages for mRNA-based vaccines and cancer immunotherapies, notably participating in the South Korean K-mRNA consortium.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Lipid nanoparticle delivery therapymRNA-based drugsNanoparticleVaccine
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
ST PharmGC BiopharmaK-mRNA Consortium
Beyond the preview
Go deeper on Nano Intelligent Biomedical Engineering.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nano Intelligent Biomedical Engineering.